Merck, the manufacturer of Vioxx, has begun to make partial payments to some qualified Vioxx claimants who had heart attacks as direct result of taking their once famed drug. Of the more than 50,000 potential claims, only a few hundred were paid in August, and most other pending claims will actually be paid at a [...]
According to Reuters out of New York, Merck & Co, and Schering-Plough Corp will pay $41.5 million to settle class-action lawsuits over their shared cholesterol drugs Vytorin, and Zetia, the companies said on Wednesday, August 5, 2009.
The lawsuits involved allegations arising from the Enhance clinical trial, whose results released in January 2008, raised serious questions about [...]
It is now going on almost five years since the drug Vioxx was pulled from store shelves by its manufacturer, Merck, but it appears the legal system will be seeing the class action against Merck for sometime to come.
On May 26, 2009, the Supreme Court agreed to hear Merck’s appeal in a shareholder lawsuit that [...]
